Health Boards
Thu-10-12-2015, 20:02 PM
They say they are trying to give access to more patients with their biosimilars...
Does that mean they will be selling at prices the insurance companies are willing to pay for.
It's a shame at the moment only 5% of severe sufferers have access to these drugs and if biosimilars makes them affordable for more people it can only be a good thing in my opinion
Does that mean they will be selling at prices the insurance companies are willing to pay for.
It's a shame at the moment only 5% of severe sufferers have access to these drugs and if biosimilars makes them affordable for more people it can only be a good thing in my opinion
